There is a wide variety of ion channel types with various types of blockers, making research in this field very complicated. To reduce this complexity, it is essential to study ion channels and their blockers independently. Scorpion toxins, a major class of blockers, are charged short peptides with high affinities for potassium channels. Their high selectivity and inhibitory properties make them an important pharmacological tool for treating autoimmune or nervous system disorders. Scorpion toxins typically have highly charged surfaces and-like other proteins-an intrinsic ability to bind ions (Friedman J Phys Chem B 115(29):9213-9223, 1996; Baldwin Biophys J 71(4):2056-2063, 1996; Vrbka et al. Proc Natl Acad Sci USA 103(42):15440-15444, 2006a; Vrbka et al. J Phys Chem B 110(13):7036-43, 2006b). Thus, their effects on potassium channels are usually investigated in various ionic solutions. In this work, computer simulations of protein structures were performed to analyze the structural properties of the key residues (i.e., those that are presumably involved in contact with the surfaces of the ion channels) of 12 scorpion toxins. The presence of the two most physiologically abundant cations, Na(+) and K(+), was considered. The results indicated that the ion-binding properties of the toxin residues vary. Overall, all of the investigated toxins had more stable structures in ionic solutions than in water. We found that both the number and length of elements in the secondary structure varied depending on the ionic solution used (i.e., in the presence of NaCl or KCl). This study revealed that the ionic solution should be chosen carefully before performing experiments on these toxins. Similarly, the influence of these ions should be taken into consideration in the design of toxin-based pharmaceuticals.

Department of Biological Chemistry University of Michigan Ann Arbor MI 48109 USA

Institute of Applied Physiology Ulm University Ulm Germany

Institute of Organic Chemistry and Biochemistry Academy of Sciences of the Czech Republic Flemingovo nám 2 16610 Prague 6 Czech Republic

J Heyrovský Institute of Physical Chemistry Academy of Sciences of the Czech Republic v v i Dolejskova 3 18223 Prague 8 Czech Republic

Zobrazit více v PubMed

Neuron. 1996 Feb;16(2):399-406 PubMed

Proteins. 1997 Nov;29(3):321-33 PubMed

Biophys J. 2001 Apr;80(4):1659-69 PubMed

Biochemistry. 2001 Sep 18;40(37):10998-1006 PubMed

PLoS One. 2012;7(10):e46388 PubMed

Curr Med Chem. 2004 Mar;11(5):595-605 PubMed

Biochemistry. 1994 Nov 29;33(47):14256-63 PubMed

Biochemistry. 2001 May 22;40(20):5942-53 PubMed

J Phys Chem B. 2011 Oct 6;115(39):11490-500 PubMed

Sci Rep. 2014 Mar 28;4:4509 PubMed

Biochem J. 2004 Jan 1;377(Pt 1):25-36 PubMed

Nature. 2006 Apr 13;440(7086):959-62 PubMed

Protein Sci. 1995 Aug;4(8):1478-89 PubMed

Biochim Biophys Acta. 2010 Apr;1804(4):821-8 PubMed

J Biol Chem. 2000 May 5;275(18):13605-12 PubMed

Biochemistry. 2001 Sep 18;40(37):10987-97 PubMed

Biophys J. 2012 Feb 22;102(4):907-15 PubMed

J Biomol Struct Dyn. 2012;29(4):815-24 PubMed

Biopolymers. 1983 Dec;22(12):2577-637 PubMed

Biophys J. 2004 Jun;86(6):3542-55 PubMed

Neuron. 1992 Aug;9(2):307-13 PubMed

Biophys J. 2011 Dec 7;101(11):2652-60 PubMed

J Phys Chem B. 2013 May 30;117(21):6394-402 PubMed

Neuron. 1994 Jun;12(6):1377-88 PubMed

J Phys Chem B. 2011 Jul 28;115(29):9213-23 PubMed

Biochem J. 2005 Jan 1;385(Pt 1):95-104 PubMed

Science. 1995 Apr 14;268(5208):307-10 PubMed

Proc Natl Acad Sci U S A. 1988 Jan;85(2):401-5 PubMed

J Pept Sci. 1997 Jul-Aug;3(4):314-9 PubMed

Biochem J. 2004 Jan 1;377(Pt 1):37-49 PubMed

Biophys J. 2000 Aug;79(2):776-87 PubMed

Nature. 2006 Mar 23;440(7083):440-7 PubMed

J Biol Chem. 2000 Dec 15;275(50):39345-53 PubMed

Toxicon. 2001 Jun;39(6):739-48 PubMed

FEBS Lett. 1998 Jun 16;429(3):381-4 PubMed

Biophys J. 2002 Nov;83(5):2370-85 PubMed

J Gen Physiol. 1988 Mar;91(3):317-33 PubMed

Biochim Biophys Acta. 2002 Oct 11;1565(2):294-307 PubMed

Biopolymers. 1991 Sep;31(10):1213-20 PubMed

Biochemistry. 1997 Mar 11;36(10):2763-71 PubMed

Eur J Biochem. 1999 Sep;264(2):287-300 PubMed

Structure. 1995 May 15;3(5):435-48 PubMed

Proteins. 1999 Mar 1;34(4):417-26 PubMed

Neuron. 1995 Nov;15(5):1169-81 PubMed

Toxins (Basel). 2012 Nov 01;4(11):1082-119 PubMed

Biochimie. 1998 Feb;80(2):151-4 PubMed

J Membr Biol. 2001 Jan 1;179(1):13-25 PubMed

Proc Natl Acad Sci U S A. 2008 May 13;105(19):6809-12 PubMed

Toxicon. 2003 Aug;42(2):199-205 PubMed

Biophys Chem. 2007 Jul;128(2-3):95-104 PubMed

J Phys Chem B. 2008 Sep 25;112(38):12073-80 PubMed

J Mol Graph. 1996 Feb;14(1):33-8, 27-8 PubMed

Biophys J. 2013 Oct 15;105(8):1829-37 PubMed

BMC Struct Biol. 2011 Jan 25;11:3 PubMed

PLoS One. 2008 Jun 04;3(6):e2359 PubMed

Biochimie. 2000 Sep-Oct;82(9-10):861-8 PubMed

J Toxicol. 2012;2012:103608 PubMed

Biophys J. 2000 May;78(5):2382-91 PubMed

J Phys Chem B. 2012 May 3;116(17):5132-40 PubMed

Biopolymers. 1985 Jun;24(6):1057-74 PubMed

Science. 1998 Apr 3;280(5360):69-77 PubMed

Biochemistry. 1992 Sep 1;31(34):7756-64 PubMed

Biochemistry. 1994 Dec 20;33(50):15061-70 PubMed

Biochemistry. 2004 Oct 5;43(39):12469-76 PubMed

J Gen Physiol. 2004 Mar;123(3):265-79 PubMed

Neuron. 1995 Jul;15(1):5-10 PubMed

Trends Pharmacol Sci. 2004 May;25(5):280-9 PubMed

Biochemistry. 1995 Dec 26;34(51):16563-73 PubMed

FEBS Lett. 2001 Sep 21;505(3):369-73 PubMed

FEBS Lett. 2003 Jan 30;535(1-3):29-33 PubMed

Protein Sci. 1999 Dec;8(12):2672-85 PubMed

Biophys J. 2003 Mar;84(3):1628-41 PubMed

Trends Pharmacol Sci. 1999 Nov;20(11):444-7 PubMed

Biochemistry. 1997 Feb 11;36(6):1223-32 PubMed

Biochemistry. 1994 Jan 18;33(2):443-50 PubMed

Indian J Med Res. 2009 Mar;129(3):223-32 PubMed